Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
| Revenue (Most Recent Fiscal Year) | $31.69B |
| Net Income (Most Recent Fiscal Year) | $5.04B |
| PE Ratio (Current Year Earnings Estimate) | 15.03 |
| PE Ratio (Trailing 12 Months) | 14.87 |
| PEG Ratio (Long Term Growth Estimate) | 2.47 |
| Price to Sales Ratio (Trailing 12 Months) | 3.41 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.02 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.39 |
| Pre-Tax Margin (Trailing 12 Months) | 18.27% |
| Net Margin (Trailing 12 Months) | 14.03% |
| Return on Equity (Trailing 12 Months) | 13.52% |
| Return on Assets (Trailing 12 Months) | 7.77% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.76 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.41 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.40 |
| Inventory Turnover (Trailing 12 Months) | 2.13 |
| Book Value per Share (Most Recent Fiscal Quarter) | $39.30 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.30 |
| Earnings per Share (Most Recent Fiscal Year) | $5.55 |
| Diluted Earnings per Share (Trailing 12 Months) | $3.22 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 1.33B |
| Free Float | 1.33B |
| Market Capitalization | $105.16B |
| Average Volume (Last 20 Days) | 7.65M |
| Beta (Past 60 Months) | 0.77 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.29% |
| Percentage Held By Institutions (Latest 13F Reports) | 79.81% |
| Annual Dividend (Based on Last Quarter) | $2.72 |
| Dividend Yield (Based on Last Quarter) | 3.44% |